What does trilink — acquisitions mean?

Tracks the capital deployed for the purchase of businesses or technologies specifically integrated into the TriLink segment. This metric highlights the company's inorganic growth strategy and its commitment to expanding its nucleic acid production capabilities. It is a critical indicator of how the company allocates capital to maintain a competitive edge in drug therapy and vaccine development support.

Maravai LifeSciences Holdings, Inc. (MRVI) TriLink — Acquisitions

Screener

Other segment segments

Cygnus

$0—

Similar metrics at other companies

HDOther — Acquisitions

$109M+419%

HPQPrinting — Acquisitions

$0-100%

CSCOAmericas — Acquisitions

$18M-18.2%

LZBRetail — Acquisitions

$14.41M+275%

LZBWholesale — Acquisitions

$0—

ABMAviation — Acquisitions

$0—

Other financials

Income statement

See full

Revenue$51.4M+8.5%

Gross profit$20.7M+166%

Operating income-$15.1M+77.2%

Net income-$12.4M+68.6%

EPS (diluted)-$0.08+70.4%

Balance sheet

See full

Cash & equivalents$70.6M-73.8%

Total debt$176.7M-52.4%

Total equity$204.6M-23.0%

Total assets$603.7M-32.7%

Cash flow

See full

Operating cash flow$4.0M+139%

CapEx$370.0K-87.1%

Free cash flow$3.6M+128%

Valuation

See full

Market cap$918.96M+210%

Enterprise value$1.03B+158%

P/S4.4×+3.1×

Profitability

See full

Gross margin34.9%+4.4pp

Operating margin-56.1%-21.3pp

Net margin-37.1%-13.6pp

FCF margin-17.2%—

Returns & leverage

See full

Return on equity-32.9%-9.4pp

Debt / equity0.9×-0.5×

Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-K, filed February 26, 2026.

Filed: Feb 26, 2026, 4:06 PM EST
Fiscal year: FY2025
Accession: 0001823239-26-000011

Line item	Tri Link (1)	Cygnus (2)	Total
Balance as of December 31, 2024	$39,950	$119,928	$159,878
Acquisitions	12,207	—	12,207
Impairment	(42,884)	—	(42,884)
Foreign currency translation	228	—	228
Balance as of December 31, 2025	$9,501	$119,928	$129,429

Item 8. Financial Statements and Supplementary Data

FAQ

What is Maravai LifeSciences Holdings, Inc.'s trilink — acquisitions?: Maravai LifeSciences Holdings, Inc. (MRVI) reported trilink — acquisitions of $3.05M in Q4 2025.
What does trilink — acquisitions mean?: Tracks the capital deployed for the purchase of businesses or technologies specifically integrated into the TriLink segment. This metric highlights the company's inorganic growth strategy and its commitment to expanding its nucleic acid production capabilities. It is a critical indicator of how the company allocates capital to maintain a competitive edge in drug therapy and vaccine development support.